Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 26, 2022; 10(33): 12164-12174
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12164
Table 2 Follow-up data of six lung adenocarcinoma patients with co-mutations of EGFR and ALK genes
Case
1#
2#
3#
4#
5#
6#
1st line Gefitinib1, 1 mo GP, 1 course SurgeryGefitinib, 6 moGefitinib, 3 moErlotinib, 4 mo
2nd line -Gefitinib, 2 mo GP2, 4 courses --Crizotinib3, 15 d
3rd line -GP, 1 course Gefitinib, 2 mo - - PC4, 2 courses
Status Lost DeadCR LostDeadDead
PFS Unknown2 mo Unknown6 mo3 mo4 mo